Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Return on Assets (2021 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Return on Assets for 5 consecutive years, with 0.55% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 10.0% to 0.55% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.55% through Dec 2025, up 10.0% year-over-year, with the annual reading at 0.43% for FY2025, 9.0% up from the prior year.
  • Return on Assets hit 0.55% in Q4 2025 for Bolt Biotherapeutics, up from 0.61% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.21% in Q2 2021 to a low of 0.68% in Q1 2025.
  • Historically, Return on Assets has averaged 0.44% across 5 years, with a median of 0.39% in 2023.
  • Biggest five-year swings in Return on Assets: fell -24bps in 2024 and later increased 10bps in 2025.
  • Year by year, Return on Assets stood at 0.29% in 2021, then dropped by -29bps to 0.37% in 2022, then decreased by -11bps to 0.41% in 2023, then crashed by -57bps to 0.65% in 2024, then grew by 15bps to 0.55% in 2025.
  • Business Quant data shows Return on Assets for BOLT at 0.55% in Q4 2025, 0.61% in Q3 2025, and 0.63% in Q2 2025.